AREV Life Sciences Global Corp.

AREV

CA04019J1093

Food Processing

Market Closed - Canadian Securities Exchange Other stock markets 12:06:40 2023-07-11 pm EDT			5-day change	1st Jan Change
0.09 ^CAD	-10.00%		-.--%	-.--%

2023	AREV Life Sciences Global Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	AREV Life Sciences Global Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI

AREV Life Sciences Global Corp. Announces Executive Changes

December 23, 2021 at 09:19 pm EST

AREV Life Sciences Global Corp. announce the appointment of Allan Echino as Director effective December 21, 2021 and Denby Greenslade as interim Chief Financial Officer (CFO), effective December 17, 2021. The Company announces the resignation of Mr. Brian Cameron as Chief Financial Officer of the Company.

Latest news about AREV Life Sciences Global Corp.

AREV Life Sciences Global Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Dec. 08	CI
AREV Life Sciences Global Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	Dec. 08	CI
AREV Life Sciences Global Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	Nov. 28	CI
AREV Life Sciences Global Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	Nov. 17	CI
AREV Life Sciences Global Corp. (CNSX : AREV) cancelled the acquisition of Fiberlab, Inc.	23-03-26	CI
AREV Life Sciences Global Corp. cancelled the transaction announced on March 14, 2023	23-03-26	CI
AREV Life Sciences Global Corp. (CNSX : AREV) entered into letter on intent to acquire Fiberlab, Inc for $7 million.	23-03-14	CI
AREV Life Sciences Global Corp. announced that it expects to receive CAD 7.548 million in funding	23-03-13	CI
AREV Life Sciences Global Corp. Announces the Resignation of Melvin Maxwell from Board	23-01-09	CI
AREV Life Sciences Global Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-22	CI
AREV Life Sciences Global Corp. Announces Management Changes	22-10-28	CI
AREV Life Sciences Global Corp. Announces the Appointment of Sateesh Apte to the Scientific Advisory Board	22-08-17	CI
AREV Life Sciences Global Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-17	CI
AREV Life Sciences Global Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-26	CI
AREV Life Sciences Global Corp. Auditor Raises 'Going Concern' Doubt	22-05-01	CI
AREV Life Sciences Global Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	22-05-01	CI
AREV Life Sciences Appoint Kevin Phelps COO	22-04-22	MT
AREV Life Sciences Global Corporation Announces Engagement of TransBIOTech to Facilitate Preclinical Therapeutic Pipeline Development	22-04-21	CI
AREV Life Sciences Global Corporation Appoints Brian V. Elliott to its Board of Directors	22-04-19	CI
AREV Life Sciences Global Corp. Appoints Kevin Phelps as Chief Operating Officer	22-04-08	CI
AREV Life Sciences Global Corp. Completes Lab and Fungi Fruiting Room Build	22-02-23	CI
AREV Life Sciences Global Corp. Appoints Douglas Sorocco to Its Scientific Advisory Committee	22-02-17	CI
AREV Life Sciences Global Corp. Announces Executive Changes	21-12-23	CI
AREV Life Sciences Global Corp Appoints Allan Echino as Director	21-12-23	CI
AREV Life Sciences Global Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-29	CI

Chart AREV Life Sciences Global Corp.

Duration

Period

More charts

Company Profile

AREV Life Sciences Global Corp. is a Canada-based fully integrated, early-stage life science discovery company. The Company produces ingredients and formulates therapeutic interventions with plans to deliver innovation in clinical nutrition, supplements, topicals and rational drug design, based on science. Its business model leverages its core competency of extraction to produce ingredients and compounds for its pipeline of products. The Companyâs nutraceutical product formulations seek to be sold under its BARE and Wright and Well brands or produced for third parties on a licensed white label basis. Its BARE and Wright and Well Brands of finished products include natural health products, including cannabidiol (CBD)-infused products such as Canna-Mulsion and NaturVax, an anti- viral supplement; NaturRelax, a natural Sleep Aid; Natur Relief, an anti- inflator and pain relief product, and a line of CBD skincare products and medicinal oils and edibles.

Sector

Food Processing

Calendar

2024-05-29 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Special Foods & Wellbeing Products

	1st Jan change	Capi.
AREV LIFE SCIENCES GLOBAL CORP.	-.--%	2.09M
ZHEJIANG NHU COMPANY LTD.	+8.20%	7.78B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	+10.20%	6.52B
BYHEALTH CO., LTD	-8.10%	3.67B
THE SIMPLY GOOD FOODS COMPANY	-13.13%	3.44B
XIAMEN KINGDOMWAY GROUP COMPANY	-14.57%	1.17B
SIRIO PHARMA CO., LTD.	+8.34%	934M
HERBALIFE LTD.	-42.27%	879M
USANA HEALTH SCIENCES, INC.	-18.90%	836M
JAMIESON WELLNESS INC.	-16.45%	802M